re: Ann: Prima BioMed's CVac granted Fast...
From Southoz
"From an ethics perspective ... I’m on an Australian HCREC. The idea that a company starts an oncology trial, hopes for good interim results so that it can raise sufficient funds to complete it is not something that would ever be approved. And if it had been approved this news would be causing ripples. In Europe who knows though"
I think he has a good point there, as far as fairness and courtesy to these patients who agree to entering a trial is concerned and it hadn't occured to me before but having enough funds to go to completion should surely be a requirement. Perhaps the Europeans see that differently as Southoz says. The company seems very confident lately as I have observed from announcements and presentations , so maybe another left field announcement about funds to see CAN-004B go to completion.
Also from Southoz's post, can anyone tell me what HCREC means?
PRR Price at posting:
4.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)